Lyell Immunopharma (LYEL) Profit After Tax (2020 - 2025)
Historic Profit After Tax for Lyell Immunopharma (LYEL) over the last 6 years, with Q3 2025 value amounting to -$38.8 million.
- Lyell Immunopharma's Profit After Tax rose 1286.81% to -$38.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$325.7 million, marking a year-over-year decrease of 5964.59%. This contributed to the annual value of -$343.0 million for FY2024, which is 4618.38% down from last year.
- Per Lyell Immunopharma's latest filing, its Profit After Tax stood at -$38.8 million for Q3 2025, which was up 1286.81% from -$42.7 million recorded in Q2 2025.
- In the past 5 years, Lyell Immunopharma's Profit After Tax ranged from a high of -$8.4 million in Q4 2022 and a low of -$191.9 million during Q4 2024
- Moreover, its 5-year median value for Profit After Tax was -$52.9 million (2023), whereas its average is -$60.2 million.
- Its Profit After Tax has fluctuated over the past 5 years, first skyrocketed by 8996.85% in 2022, then tumbled by 53034.42% in 2023.
- Quarter analysis of 5 years shows Lyell Immunopharma's Profit After Tax stood at -$83.7 million in 2021, then soared by 89.97% to -$8.4 million in 2022, then tumbled by 530.34% to -$52.9 million in 2023, then plummeted by 262.62% to -$191.9 million in 2024, then soared by 79.76% to -$38.8 million in 2025.
- Its Profit After Tax was -$38.8 million in Q3 2025, compared to -$42.7 million in Q2 2025 and -$52.2 million in Q1 2025.